Group One Trading’s Neos Therapeutics, Inc NEOS Stock Holding History

Group One Trading’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,900	Closed	-$7K	–	6015
2019 Q4	$7K	Hold	4,900	–	–	﹤0.01%	4703
2019 Q3	$7K	Buy	+4,900	New	+$7.93K	﹤0.01%	4701
2019 Q2	–	Sell	-3,000	Closed	-$8K	–	5629
2019 Q1	$8K	Sell	3,000 -10,600	-78%	-$24.9K	﹤0.01%	4352
2018 Q4	$22K	Sell	13,600 -23,400	-63%	-$65.7K	﹤0.01%	3995
2018 Q3	$179K	Buy	37,000 +30,000	+429%	+$170K	﹤0.01%	3088
2018 Q2	$44K	Sell	7,000 -36,300	-84%	-$271K	﹤0.01%	4026
2018 Q1	$359K	Sell	43,300 -26,300	-38%	-$251K	﹤0.01%	2312
2017 Q4	$710K	Buy	69,600 +47,700	+218%	+$458K	0.01%	1970
2017 Q3	$200K	Buy	21,900 +1,500	+7%	+$11.4K	﹤0.01%	2759
2017 Q2	$149K	Buy	+20,400	New	+$154K	﹤0.01%	2853

Group One Trading's NEOS Position: Q1 2021 in Review

Group One Trading sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 8,605 shares — an estimated $5K sold.

Group One Trading first reported a position in NEOS in Q2 2017 and held it in 15 quarters. The position peaked at $683K in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Group One Trading reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Group One Trading sold 8,605 Neos Therapeutics, Inc shares in Q1 2021, an estimated $5K.
Group One Trading first reported a position in Neos Therapeutics, Inc in Q2 2017 and held it in 15 quarters.
Group One Trading's Neos Therapeutics, Inc position peaked at $683K in Q4 2017.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.